Atopic eczema or atopiform dermatitis

Experimental Dermatology

Volumn 19, Issue 4, 2010, Pages 325-331

  Bos, Jan D ^a   Brenninkmeijer, Elian E A ^a   Schram, Mandy E ^a   Middelkamp Hup, Maritza A ^a   Spuls, Phyllis I ^a   Smitt, J Henk Sillevis ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Allergen specific IgE; Atopic eczema; Atopiform dermatitis; Atopy

Indexed keywords

ALLERGEN; APRIL PROTEIN; FILAGGRIN; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; INTERLEUKIN 31; STEROID; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ARTICLE; ATOPIC DERMATITIS; ATOPY; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE SEVERITY; GENE MUTATION; HUMAN; IMMUNOPATHOGENESIS; LIFESTYLE MODIFICATION; MOLECULAR RECOGNITION; PHENOTYPE; PHOTOTHERAPY; PREVALENCE; PRURITUS; SCORING SYSTEM; TISSUE DISTRIBUTION;

DERMATITIS, ATOPIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOGLOBULIN E; TERMINOLOGY AS TOPIC;

EID: 77951866768     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.01024.x     Document Type: Article

References (82)

1. Wallach D, Taïb A, Tilles G. Histoire de la dermatite atopique. 2004, Issy les Moulineaux
2. Von Pirquet C E. Allergie. München Med Wochenschr 1906, Iiii.
3. Coca A F, Cooke R A. On the classification of the phenomena of hypersensitiveness. J Immunol 1923, 8:163-182.
4. Ishizaka K, Ishizaka T, Hornbrook M M. Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity. J Immunol 1966, 97:75-85.
5. Bruijnzeel-Koomen C A, Mudde G C, Bruijnzeel P L. The presence of IgE molecules on epidermal Langerhans cells in atopic dermatitis and their significance for its pathogenesis. Allerg Immunol (Paris) 1989, 21:219-223.
6. Bos J D, Kapsenberg M L, Smitt J H. Pathogenesis of atopic eczema. Lancet 1994, 343:1338-1341.
7. Wierenga E A, Snoek M, Jansen H M. Human atopen-specific types 1 and 2 T helper cell clones. J Immunol 1991, 147:2942-2949.
8. Bos J D. Atopiform dermatitis. Br J Dermatol 2002, 147:426-429.
9. Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis - a prospective follow-up to 7 years of age. Allergy 2000, 55:240-245.
10. Bieber T. Atopic dermatitis. N Engl J Med 2008, 358:1483-1494.
11. Burton J L. The logic of dermatological diagnosis. Dowling oration 1980. Clin Exp Dermatol 1981, 6:1-21.
12. Barker J N, Palmer C N, Zhao Y. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol 2007, 127:564-567.
13. Morar N, Cookson W O, Harper J I. Filaggrin mutations in children with severe atopic dermatitis. J Invest Dermatol 2007, 127:1667-1672.
14. Nomura T, Sandilands A, Akiyama M. Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol 2007, 119:434-440.
15. Palmer C N, Irvine A D, Terron-Kwiatkowski A. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006, 38:441-446.
16. Ruether A, Stoll M, Schwarz T. Filaggrin loss-of-function variant contributes to atopic dermatitis risk in the population of Northern Germany. Br J Dermatol 2006, 155:1093-1094.
17. Sandilands A, Terron-Kwiatkowski A, Hull P R. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007, 39:650-654.
18. Weidinger S, Illig T, Baurecht H. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006, 118:214-219.
19. Baurecht H, Irvine A D, Novak N. Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol 2007, 120:1406-1412.
20. Rodriguez E, Baurecht H, Herberich E. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009, 123:1361-1370.
21. Brenninkmeijer E E, Schram M E, Leeflang M M. Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol 2008, 158:754-765.
22. Schmid-Grendelmeier P, Simon D, Simon H U. Epidemiology, clinical features, and immunology of the " intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy 2001, 56:841-849.
23. Wuthrich B. Neurodermatitis atopica sive constitutionalis. Ein pathogenetisches Modell aus der Sicht des Allergologen. Akt Dermatol 1983, 9:1-7.
24. Akdis C A, Akdis M, Simon D. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol 1999, 113:628-634.
25. Johansson S G, Bieber T, Dahl R. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004, 113:832-836.
26. Wuthrich B, Schmid-Grendelmeier P. The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE-associated (" extrinsic" ) and the nonallergic (" intrinsic" ) AEDS. J Investig Allergol Clin Immunol 2003, 13:1-5.
27. Hanifin J M, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980, 92:44-47.
28. Williams H C, Burney P G, Strachan D. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol 1994, 131:397-405.
29. Williams H C, Burney P G, Hay R J. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994, 131:383-396.
30. Williams H C, Burney P G, Pembroke A C. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994, 131:406-416.
31. Popescu C M, Popescu R, Williams H. Community validation of the United Kingdom diagnostic criteria for atopic dermatitis in Romanian schoolchildren. Br J Dermatol 1998, 138:436-442.
32. Williams H C, Burney P G, Pembroke A C. Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. Diagnostic Criteria for Atopic Dermatitis Working Party. Br J Dermatol 1996, 135:12-17.
33. Bos J D, Van Leent E J, Sillevis Smitt J H. The millennium criteria for the diagnosis of atopic dermatitis. Exp Dermatol 1998, 7:132-138.
34. Wadonda-Kabondo N, Sterne J A, Golding J. A prospective study of the prevalence and incidence of atopic dermatitis in children aged 0-42 months. Br J Dermatol 2003, 149:1023-1028.
35. Ninan T K, Russell G. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. BMJ 1992, 304:873-875.
36. Haileamlak A, Lewis S A, Britton J. Validation of the International Study of Asthma and Allergies in Children (ISAAC) and U.K. criteria for atopic eczema in Ethiopian children. Br J Dermatol 2005, 152:735-741.
37. Johnke H, Vach W, Norberg L A. A comparison between criteria for diagnosing atopic eczema in infants. Br J Dermatol 2005, 153:352-358.
38. Kramer U, Schafer T, Behrendt H. The influence of cultural and educational factors on the validity of symptom and diagnosis questions for atopic eczema. Br J Dermatol 1998, 139:1040-1046.
39. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998, 351:1225-1232.
40. Chan H H, Pei A, Van K C. Validation of the Chinese translated version of ISAAC core questions for atopic eczema. Clin Exp Allergy 2001, 31:903-907.
41. Flohr C, Weinmayr G, Weiland Deceased S K. How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol 2009 Oct, 161:846-853.
42. Taylor B, Wadsworth J, Wadsworth M. Changes in the reported prevalence of childhood eczema since the 1939-45 war. Lancet 1984, 2:1255-1257.
43. Krause T, Koch A, Friborg J. Frequency of atopy in the Arctic in 1987 and 1998. Lancet 2002, 360:691-692.
44. Macan J, Varnai V M, Maloca I. Increasing trend in atopy markers prevalence in a Croatian adult population between 1985 and 1999. Clin Exp Allergy 2007, 37:1756-1763.
45. Eder W, Ege M J, von M E. The asthma epidemic. N Engl J Med 2006, 355:2226-2235.
46. Zar H J, Ehrlich R I, Workman L. The changing prevalence of asthma, allergic rhinitis and atopic eczema in African adolescents from 1995 to 2002. Pediatr Allergy Immunol 2007, 18:560-565.
47. Flohr C, Pascoe D, Williams H C. Atopic dermatitis and the 'hygiene hypothesis': too clean to be true? Br J Dermatol 2005, 152:202-216.
48. Holt P G. Parasites, atopy, and the hygiene hypothesis: resolution of a paradox? Lancet 2000, 356:1699-1701.
49. McKeever T M, Lewis S A, Smith C. The importance of prenatal exposures on the development of allergic disease: a birth cohort study using the West Midlands General Practice Database. Am J Respir Crit Care Med 2002, 166:827-832.
50. Sherriff A, Golding J. Hygiene levels in a contemporary population cohort are associated with wheezing and atopic eczema in preschool infants. Arch Dis Child 2002, 87:26-29.
51. Brenninkmeijer E E, Spuls P I, Legierse C M. Clinical differences between atopic and atopiform dermatitis. J Am Acad Dermatol 2008, 58:407-414.
52. Flohr C, Johansson S G, Wahlgren C F. How atopic is atopic dermatitis? J Allergy Clin Immunol 2004, 114:150-158.
53. Bos J D, Sillevis Smitt J H. Atopic dermatitis. J Eur Acad Dermatol Venereol 1996, 7:101-114.
54. Schudel P, Wuthrich B. [Clinical course of childhood atopic neurodermatitis. A catamnestic study of 121 cases]. Z Hautkr 1985, 60:479-486.
55. Yates V M, Kerr R E, MacKie R M. Early diagnosis of infantile seborrhoeic dermatitis and atopic dermatitis - clinical features. Br J Dermatol 1983, 108:633-638.
56. Rudikoff D, Lebwohl M. Atopic dermatitis. Lancet 1998, 351:1715-1721.
57. Halkjaer L B, Loland L, Buchvald F F. Development of atopic dermatitis during the first 3 years of life: the Copenhagen prospective study on asthma in childhood cohort study in high-risk children. Arch Dermatol 2006, 142:561-566.
58. Komatsu N, Saijoh K, Kuk C. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients. Exp Dermatol 2007, 16:513-519.
59. Vasilopoulos Y, Cork M J, Teare D. A nonsynonymous substitution of cystatin A, a cysteine protease inhibitor of house dust mite protease, leads to decreased mRNA stability and shows a significant association with atopic dermatitis. Allergy 2007, 62:514-519.
60. Favre A. Identification of filaggrin in Hassall's corpuscle by histochemical and immunohistochemical methods. Acta Anat (Basel) 1989, 135:71-76.
61. Watanabe N, Wang Y H, Lee H K. Hassall's corpuscles instruct dendritic cells to induce CD4 + CD25 + regulatory T cells in human thymus. Nature 2005, 436:1181-1185.
62. Olesen A B, Andersen G, Jeppesen D L. Thymus is enlarged in children with current atopic dermatitis. A cross-sectional study. Acta Derm Venereol 2005, 85:240-243.
63. Bang K, Lund M, Wu K. CD4 + CD8 + (thymocyte-like) T lymphocytes present in blood and skin from patients with atopic dermatitis suggest immune dysregulation. Br J Dermatol 2001, 144:1140-1147.
64. Homey B, Steinhoff M, Ruzicka T. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006, 118:178-189.
65. Kondo H, Ichikawa Y, Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol 1998, 28:769-779.
66. Strid J, Hourihane J, Kimber I. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol 2004, 34:2100-2109.
67. Lebre M C, van Capel T M, Bos J D. Aberrant function of peripheral blood myeloid and plasmacytoid dendritic cells in atopic dermatitis patients. J Allergy Clin Immunol 2008, 122:969-976.
68. Novak N, Valenta R, Bohle B. FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol 2004, 113:949-957.
69. Grewe M, Gyufko K, Schopf E. Lesional expression of interferon-gamma in atopic eczema. Lancet 1994, 343:25-26.
70. Hamid Q, Boguniewicz M, Leung D Y. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994, 94:870-876.
71. Thepen T, Langeveld-Wildschut E G, Bihari I C. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 1996, 97:828-837.
72. Werfel T, Morita A, Grewe M. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. J Invest Dermatol 1996, 107:871-876.
73. Park C O, Lee H J, Lee J H. Increased expression of CC chemokine ligand 18 in extrinsic atopic dermatitis patients. Exp Dermatol 2008, 17:24-29.
74. Kakinuma T, Nakamura K, Wakugawa M. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001, 107:535-541.
75. Matsushita T, Fujimoto M, Echigo T. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis. Exp Dermatol 2008, 17:197-202.
76. Di C A, Di M P, Nestle F O. A role for Th17 cells in the immunopathogenesis of atopic dermatitis? J Invest Dermatol 2008, 128:2569-2571.
77. Bilsborough J, Leung D Y, Maurer M. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2006, 117:418-425.
78. Neis M M, Peters B, Dreuw A. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 2006, 118:930-937.
79. Sonkoly E, Muller A, Lauerma A I. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006, 117:411-417.
80. Gutzmer R, Mommert S, Gschwandtner M. The histamine H4 receptor is functionally expressed on T(H)2 cells. J Allergy Clin Immunol 2009, 123:619-625.
81. Raap U, Wichmann K, Bruder M. Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol 2008, 122:421-423.
82. Purwar R, Langer K, Werfel T. Polymorphisms within the C3 gene are associated with specific IgE levels to common allergens and super-antigens among atopic dermatitis patients. Exp Dermatol 2009, 18:30-34.